Compare gera Therapeutics vs Zystor Therapeutics
Customers evaluate the quality of gera Therapeutics's products using the following success metrics.
Overview
gera Therapeutics is 24 yrs old and is based in Canada.
Aegera Therapeutics, located in Montreal, Canada, is a business unit of Pharmascience focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has two oncology programs in clinical development. Aegera is also dedicated to identifying novel development candidates based upon its core technologies, internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
Zystor Therapeutics is 20 yrs old and is based in United States.
ZyStor Therapeutics is a biotechnology company developing therapeutics, with the potential to significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs).
Demo Video
Leadership
Michael J Berendt (Chief Executive Officer, President)
Allan Goldberg (Founder)
Investors
Pharmascience, GrowthWorks
BioMarin Pharmaceutical, Apjohn Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because gera Therapeutics has not claimed their profile.
Work for gera Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for gera Therapeutics?
Claim your profile now.
Information not available because Zystor Therapeutics has not claimed their profile.
Work for Zystor Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Zystor Therapeutics?
Claim your profile now.